Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 117-123

  Jia, Yue Xia ^a   Yang, Jing Hui ^a   Pan, Chun Shui ^a   Geng, Bin ^a   Zhang, Jing ^a   Xiao, Yang ^a   Zhao, Jing ^a   Gerns, Helen ^c   Yang, Jun ^c   Chang, Jaw Kang ^c   Wen, Jin Kun ^d   Tang, Chao Shu ^a,b   Qi, Yong Fen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c PHOENIX PHARMACEUTICALS INC   (United States)

^d HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Calcitonin receptor like receptor; cAMP; Intermedin; Isoproterenol; Receptor activity modifying protein

Indexed keywords

CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; INTERMEDIN; IODINE 125; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; ADRENOMEDULLIN; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR-LIKE RECEPTOR; INTERMEDIN PROTEIN, RAT; MEMBRANE PROTEIN; MESSENGER RNA; NEUROPEPTIDE; PEPTIDE FRAGMENT; RADIOACTIVE IODINE; RECEPTOR ACTIVITY MODIFYING PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOLEMMA; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; GENETICS; HEART INFARCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN BINDING; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ADRENOMEDULLIN; ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; INJECTIONS, SUBCUTANEOUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IODINE RADIOISOTOPES; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOLEMMA;

EID: 33748965702     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.054     Document Type: Article

References (25)

1. Aiyar N. Overview of calcitonin gene-related Peptide and its receptor. Sci. World J. 1 12 Suppl 1 (2001) 1
2. Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., and Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298 (1982) 240-244
3. Beltowski J., and Jamroz A. Adrenomedullin- what we know 10 years since its discovery?. Pol. J. Pharmacol. 56 (2004) 5-27
4. Boluyt M.O., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., and Lakatta E.G. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol. 269 (1995) H638-H647
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Chao J., Kato K., Zhang J.J., Dobrzynski E., Wang C., Agata J., and Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides 22 (2001) 1731-1737
7. Copp D.H. Calcitonin: discovery, development, and clinical application. Clin. Invest. Med. 17 (1994) 268-277
8. Fischer J.A., Muff R., and Born W. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs). Biochem. Soc. Trans. 30 (2002) 455-460
9. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., Du J., and Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun. 318 (2004) 756-763
10. Grimm D., Holmer S.R., Riegger G.A., and Kromer E.P. Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat. Cardiovasc. Pathol. 8 (1999) 315-323
11. Kato K., Yin H., Agata J., Yoshida H., Chao L., and Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol, Heart Circ. Physiol. 285 (2003) H1506-H1514
12. Kuwasako K., Cao Y.N., Nagoshi Y., Tsuruda T., Kitamura K., and Eto T. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins. Mol. Pharmacol. 65 (2004) 207-213
13. Niu P., Shindo T., Iwata H., Iimuro S., Takeda N., Zhang Y., Ebihara A., Suematsu Y., Kangawa K., Hirata Y., and Nagai R. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 109 (2004) 1789-1794
14. Ogoshi M., Inoue K., and Takei Y. Identification of a novel adrenomedullin gene family in teleost fish. Biochem. Biophys. Res. Commun. 311 (2003) 1072-1077
15. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., and Foord S.M. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54 (2002) 233-246
16. Qi Y.F., Bu D.F., Niu D.D., Shi Y.R., Wang S.H., Pang Y.Z., Tang C.S., and Du J.B. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 23 (2002) 1141-1147
17. Qi Y.F., Shi Y.R., Bu D.F., Pang Y.Z., and Tang C.S. Changes of adrenomedullin and receptor activity modifying protein 2 (RAMP2) in myocardium and aorta in rats with isoproterenol-induced myocardial ischemia. Peptides 24 (2003) 463-468
18. Roh J., Chang C.L., Bhalla A., Klein C., and Hsu S.Y. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J. Biol. Chem. 279 (2004) 7264-7274
19. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17 (1985) 291-306
20. Rona G., Chappel C.I., Balzas T., and Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67 (1959) 443-455
21. She F., Sun W., Mao J.M., and Wang X. Calcitonin gene-related peptide gene therapy suppresses reactive oxygen species in the pancreas and prevents mice from autoimmune diabetes. Shengli Xuebao 55 (2003) 625-632
22. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., and Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett. 556 (2004) 53-58
23. Tang C.S., and Liu M.S. Initial externalization followed by internalization of adrenergic receptors in rat heart during sepsis. Am. J. Physiol. 270 (1996) R254-R263
24. Tipnis U.R., Chopra A., Campbell G., and Boor P. Role of polyamines in atrial natriuretic peptide expression in isoproterenol-induced cardiac hypertrophy in rat. Biomed. Lett. 52 (1995) 81-86
25. Yoshimoto T., Fukai N., Sato R., Sugiyama T., Ozawa N., Shichiri M., and Hirata Y. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145 (2004) 3331-3337